CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
about
CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
description
scientific article published on 28 August 2018
@en
name
CNS Response to Osimertinib Ve ...... ced Non-Small-Cell Lung Cancer
@en
type
label
CNS Response to Osimertinib Ve ...... ced Non-Small-Cell Lung Cancer
@en
prefLabel
CNS Response to Osimertinib Ve ...... ced Non-Small-Cell Lung Cancer
@en
P2093
P356
P1476
CNS Response to Osimertinib Ve ...... ced Non-Small-Cell Lung Cancer
@en
P2093
Alessandro Bertolini
Andrew P Brown
Astrid McKeown
Byoung Chul Cho
Caicun Zhou
Eun Kyung Cho
Isamu Okamoto
Johan Vansteenkiste
Kazuhiko Nakagawa
Ki Hyeong Lee
P304
JCO2018783118
P356
10.1200/JCO.2018.78.3118
P577
2018-08-28T00:00:00Z